Recruiting Study of Epcoritamab as a Consolidation Therapy in CLL/SLL NCT07108998 Conditions CLL, CLL/SLL, Chronic Disease, +20 more Locations University of Cincinnati — Cincinnati, Ohio, United States View Trial Details
